Argenx advances as Vyvgart hits key trial endpoints for autoimmune myositis
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Headline Inflation Is Easing, but Trumpflation Isn't -- and That's a Recipe for Disaster on Wall Street
Key PointsDespite inflation concerns, the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite have all catapulted to new heights in 2026.
Ask the expert: Is this a hack for contributing £29,000 to an ISA?
Fidelity personal financial specialist Marianna Hunt is back on hand to answer your burning questions, and today a reader wants to know if they’ve found a hack on UK ISA rules. Q.
James Packer’s bets on AI pay off after sell-down in gaming shares
The billionaire former Crown Resorts owner has shifted his American investment strategy away from gaming companies back towards profitable big tech stocks.
BNPP AM Prime eyes up to five European GP stakes from current vintage; Providence to acquire valuation and property risk data biz
Providence Equity Partners announced on Friday it has entered into an agreement to acquire Hometrack. The post BNPP AM Prime eyes up to five European GP stakes from current vintage; Providence to…
Advent, Stripe in talks to up PayPal offer
PayPal Holdings is in negotiations with payments group Stripe and private equity firm Advent International over a potential takeover, with the parties discussing a higher price after an initial offer…
QSE Index opens lower
<p>Doha, Qatar: Qatar Stock Exchange (QSE) general index decreased by 55.93 points, or 0.56%, at the start of Monday's trading, reaching 9989 points, under pressure from most sectors.</p> <p>The…